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Abstract 1 
Introduction: Computerized respiratory sounds (CRS) are a simple and non-invasive measure to 2 
assess lung function. Nevertheless, their potential to detect changes after pulmonary 3 
rehabilitation (PR) is unknown and needs clarification if respiratory acoustics are to be used in 4 
clinical practice. Thus, this study investigated the short- and mid-term effects of PR on CRS in 5 
subjects with COPD. 6 
Methods: 41 subjects with COPD completed a 12-week PR program and a 3-month follow-up. 7 
Secondary outcome measures included dyspnea, self-reported sputum, FEV1, exercise 8 
tolerance, self-reported physical activity, health-related quality of life and peripheral muscle 9 
strength. CRS, the primary outcomes, were recorded at right/left posterior chest using two 10 
stethoscopes. Airflow was recorded with a pneumotachograph. Normal respiratory sounds, 11 
crackles and wheezes were analyzed with validated algorithms.  12 
Results: There was a significant effect over time in all secondary outcomes, with the exception 13 
of FEV1 and of the impact domain of the St. George’s Respiratory Questionnaire. Inspiratory and 14 
expiratory median frequency of normal respiratory sounds in the 100-300Hz band were 15 
significantly lower immediately (MD=-2.3Hz, 95%CI -4→-0.7 and MD=-1.9Hz, 95%CI -3.3→-0.5) 16 
and at 3-months (MD=-2.1Hz, 95%CI -3.6→-0.7 and MD=-2Hz, 95%CI -3.6→-0.5) post-PR. 17 
Mean number of expiratory crackles (MD=-0.8, 95%CI -1.3→-0.3) and inspiratory wheeze 18 
occupation rate (median 5.9 vs 0) were significantly lower immediately post-PR.  19 
Conclusions: CRS are sensitive to short- and mid-term effects of PR in subjects with COPD. 20 
These findings are encouraging for the clinical use of respiratory acoustics. Future research is 21 
needed to strengthen these findings and explore the potential of CRS to assess the 22 
effectiveness of other clinical interventions in COPD. 23 
 24 
Keywords: chronic lung disease; rehabilitation; computerized respiratory sounds  25 
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INTRODUCTION 1 
Chronic Obstructive Pulmonary Disease (COPD) affects 210 million people worldwide,1 placing 2 
a substantial burden on healthcare systems.2 According to the Global Initiative for Chronic 3 
Obstructive Lung Disease (GOLD), COPD is characterized by a persistent and progressive 4 
airflow limitation, but also by its systemic consequences, mainly exacerbations and 5 
comorbidities.3 Clinical manifestations are thus highly variable and no single outcome is able to 6 
assess the effectiveness of therapeutic interventions.4 In line with this evidence, the latest 7 
American Thoracic Society/European Respiratory Society research statement in COPD 8 
recognizes that the effectiveness of interventions in COPD should be established using both 9 
patient-centered and surrogate outcomes.5 10 
Pulmonary rehabilitation (PR) is one of the core components of the management of subjects 11 
with COPD.6 Patient-centered outcomes, namely health-related quality of life, exercise capacity 12 
and dyspnea, have been identified as the most important outcomes of PR.7 Surrogate 13 
outcomes, such as the forced expiratory volume in 1 second (FEV1), have also been used.
8, 9 14 
However, unlike the other outcomes, FEV1 has not been found to be responsive to PR.
8, 9 15 
Based on this evidence, and in the absence of other globally accepted surrogate outcome for 16 
lung function, it has been generally established that PR does not improve lung function in 17 
COPD.6 Nevertheless, FEV1 mainly reflects structural changes in the large airways
10 and it is 18 
well-recognized that COPD primarily targets small airways.3 Hence, there is a need to explore 19 
new surrogate outcomes to assess the effects of PR on lung function. 20 
Computerized respiratory sounds are a simple, objective and non-invasive surrogate measure 21 
to assess the function of the respiratory system.11 Computerized respiratory sounds can be 22 
divided in two main types, normal and adventitious sounds.12 Normal respiratory sounds are 23 
generated by the airflow in the respiratory tract and characterized by broad spectrum noise.12 24 
Adventitious respiratory sounds are additional sounds, which can be continuous (wheezes) or 25 
discontinuous (crackles).12 Both normal and adventitious respiratory sounds are directly related 26 
to movement of air, changes within lung morphology and presence of secretions.11, 13 In 27 
subjects with COPD, it has been shown that the number of detected wheezes, as well as their 28 
frequency, during forced expiratory maneuvers decreased after inhalation of terbutaline.14 It has 29 
also been demonstrated that it is possible to characterize the course of acute exacerbations of 30 
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COPD in two different respiratory sound patterns based on the variation of spectral 1 
parameters.15 From the limited evidence, it can be hypothesized that computerized respiratory 2 
sounds have potential to detect changes in lung function after PR. However, this is unknown as 3 
this measure has never been used to assess this intervention. 4 
Thus, this study primarily aimed to investigate the short- and mid-term effects of PR on 5 
computerized respiratory sounds in subjects with COPD. The secondary aim was to explore 6 
correlations between computerized respiratory sounds and patient-centered outcomes. 7 
METHODS 8 
Design and Subjects 9 
This was a one-arm longitudinal study investigating the effects of PR on computerized 10 
respiratory sounds in subjects with COPD. Subjects with COPD were recruited from two primary 11 
care centers. Inclusion criteria were i) diagnosis of COPD according to the GOLD,3 ii) age ≥40 12 
years old and iii) clinical stability for 1 month prior to the study (i.e., no hospital admissions or 13 
exacerbations as defined by the GOLD or changes in medication for the respiratory system).3 14 
Subjects were excluded if they presented severe psychiatric, neurologic or musculoskeletal 15 
conditions16 and/or unstable cardiovascular disease that could interfere with their performance 16 
during the exercise training sessions. The study was approved by the Center Health Regional 17 
Administration (2013-05-02) and from the National Data Protection Committee (3292/2013). 18 
Eligible subjects, identified via clinicians, were contacted by the researchers, who explained the 19 
purpose of the study and asked about their willingness to participate. When subjects agreed to 20 
participate, an appointment with the researchers was scheduled. Written informed consent was 21 
obtained prior to data collection. 22 
Intervention 23 
The PR program was held for 12 weeks and was composed of 3 weekly sessions of exercise 24 
training and 1 weekly session of psychoeducation. A detailed description of the program is 25 
provided elsewhere.17 26 
Data Collection 27 
Data were collected before and immediately after PR and then at 3-months post-PR. Two 28 
baseline computerized respiratory sound recordings with a 1-week interval before the 29 
intervention (hereafter referred to as baselines 1 and 2) were collected to confirm the stability of 30 
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subjects’ respiratory acoustics.18, 19 At baseline 1, socio-demographic, anthropometric (height 1 
and weight) and clinical (smoking habits, exacerbations in the previous year) data were first 2 
obtained. Dyspnea was assessed with the Modified British Medical Research Council (mMRC) 3 
questionnaire.3 Then, computerized respiratory sounds were recorded. 4 
Dyspnea at rest, self-reported sputum, computerized respiratory sounds, lung function, exercise 5 
tolerance, self-reported physical activity, health related quality of life and peripheral muscle 6 
strength were assessed at baseline 2 (immediately pre-PR), immediately post-PR and at 3-7 
months post-PR. Subjects’ were classified using both the GOLD spirometric classification (mild, 8 
moderate, severe-to-very severe) and the GOLD combined assessment (A, B, C and D).3 All 9 
assessments were performed by two physiotherapists and the order was standardized. 10 
Outcome Measures 11 
Secondary outcomes 12 
Dyspnea. Dyspnea at rest was assessed with the modified Borg scale.20 Subjects were asked to 13 
rate their dyspnea from 0 to 10. 14 
Self-reported sputum. Self-reported sputum was assessed using a numerical rating scale from 0 15 
to 10 anchored at either end with a statement (‘no sputum at all’=0; ‘the worst sputum 16 
imaginable’=10). Subjects were asked to select the number that best represented their 17 
subjective perception.21 18 
Lung function. A spirometric test, using a portable spirometer (MicroLab 3500, CareFusion, 19 
Kent, UK), was performed according to standardized guidelines.22 20 
Exercise tolerance. Exercise tolerance was measured using the 6-minute walk test (6MWT). 21 
Two tests were performed according to the protocol described by the American Thoracic 22 
Society23 and the best performance was considered. 23 
Peripheral muscle strength. The knee extensors muscle strength of the dominant limb was 24 
determined by 1 repetition maximum (Multigym Plus G112X, Vitoria-Gasteiz, ES).24 25 
Self-reported physical activity. The brief physical activity assessment tool, which consists of two 26 
questions assessing the frequency/duration of vigorous and moderate physical activity 27 
undertaken in a ‘‘usual’’ week, was used.25 A score higher or equal to 4 indicates that the 28 
subject is sufficiently active.25 29 
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Health-related quality of life. The St. George’s Respiratory Questionnaire (SGRQ), with its three 1 
domains (symptoms, activities and impact), was used.26 Scores range from 0 (no impairment) to 2 
100 (maximum impairment). 3 
Primary outcomes 4 
Computerized respiratory sounds. After 5-min of quiet sitting, airflow and respiratory sounds 5 
were acquired simultaneously during 20 seconds.27 Subjects were in a seated-upright position, 6 
wearing a nose clip and breathing through a mouthpiece connected to a heated 7 
pneumotachograph (3830, Hans Rudolph, Inc., Shawnee, KS, USA). A peak airflow of 0.4–0.6 8 
l/s was selected as computerized respiratory sounds have been shown to be reliable at this 9 
airflow range in subjects with COPD.28 Subjects had visual biofeedback of the flow signal (RSS 10 
100R Research Pneumotach System, Hans Rudolph, Shawnee, KS, USA) and were instructed 11 
to maintain the flow between two horizontal lines. Recording was preceded by a training phase 12 
of at least 3 breathing cycles. 13 
Recordings were performed simultaneously at right and left posterior chest (5 cm laterally from 14 
the paravertebral line and 7 cm below the scapular angle)29 using the LungSounds@UA 15 
interface.30 Two chest pieces (Classic II S.E., Littmann®, 3M, St. Paul, MN, USA), with a 16 
microphone (frequency response between 20Hz and 19kHz - TOM-1545P-R, Projects 17 
Unlimited, Inc.®, Dayton, OH, USA) and preamplifier circuit (Intelligent Sensing Anywhere®, 18 
Coimbra, PT) in the main tube, were attached to the subject’s skin with adhesive tape (Soft 19 
Cloth Surgical Tape, 3M, St. Paul, MN, USA). The analogue sound signals were further 20 
amplified and converted to digital by an audio interface (M-Audio® ProFire 2626, Irwindale, CA, 21 
USA). The signal was converted with a 24-bit resolution at a sampling rate of 44.1kHz and 22 
recorded in .wav format. 23 
All generated files were processed using algorithms written in Matlab®R2009a (Mathworks, 24 
Natick, MA, USA). Breathing phases were automatically detected using the positive and 25 
negative airflow signals. Mean inspiratory and expiratory time were then calculated. The mean 26 
airflows and tidal volumes were calculated per breathing phase using flow and volume raw 27 
signals. The flow was timed synchronized with the sound to combine the detected breathing 28 
phases with sound signals. 29 
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Crackles were detected using a multi-algorithm technique based on established algorithms.31 1 
This multi-algorithm technique showed a 7% performance improvement over the best individual 2 
algorithm.31 Wheezes were detected using an algorithm based on time-frequency analysis.32 3 
The mean number of crackles and the wheeze occupation rate (proportion of the breathing 4 
phase occupied by wheezes) during inspiration and expiration were extracted per chest location 5 
(right and left posterior chest). 6 
Normal respiratory sounds were analyzed based on the methodology proposed by 7 
Pasterkamp,33 after excluding adventitious respiratory sounds. The median frequency (F50) and 8 
the mean intensity were determined for the two most commonly analyzed frequency bands, i.e., 9 
100 to 300Hz and 300 to 600Hz and extracted per breathing phase and per chest location.33, 34 10 
Statistical Analysis 11 
A power calculation was not performed since there is no published data using computerized 12 
respiratory sounds to assess the effects of PR in subjects with COPD. Descriptive statistics 13 
were used to describe the sample and to examine the outcome measures. Differences between 14 
subjects who completed the study and dropouts were tested using independent t-tests for 15 
continuous normally distributed data, Mann-Whitney U tests for continuous non-normally 16 
distributed data and chi-square tests for categorical data.  17 
Computerized respiratory sounds were explored between right and left posterior chest, 18 
however, no significant differences were found. Hence, data from both locations were pooled to 19 
simplify the interpretability of the findings. 20 
Computerized respiratory sounds and breathing pattern (inspiratory/expiratory airflow, volume 21 
and time) parameters were compared between baseline 1 and baseline 2 with paired t-tests for 22 
normally distributed data or Wilcoxon signed-rank test for non-normally distributed data. After 23 
confirming that there were no significant differences, baseline 2, hereafter referred as baseline, 24 
was used for further analysis. 25 
Subjects were considered to have crackles or wheezes if they had at least a mean of one 26 
crackle/wheeze at baseline. To investigate differences in the number of subjects with 27 
crackles/wheezes across time points the Cochran Q test was used and the Kendall’s coefficient 28 
of concordance (Kendall’s W) was reported as estimate of effect size.35 This coefficient was 29 
interpreted as follows: very weak (0-.20), weak (.20-.40), moderate (.40-.60), strong (.60-.80) 30 
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and very strong (.80-1.00) effect.35 If the effect of time was significant, pairwise comparisons 1 
were performed using Bonferroni correction.  2 
Normality was verified for all outcome measures. When data were normally distributed, one-way 3 
analysis of variance (ANOVA) with repeated measures was used to establish the effects of time. 4 
The effect size was computed via Partial eta-squared as it is the index more commonly reported 5 
in the analysis of variance.36 Partial eta-squared (ƞ2) was interpreted as a small (≥.01), medium 6 
(≥.06) or large (≥.14) effect.36 When the effect of time was significant, post hoc analyzes were 7 
conducted with pairwise comparisons using the Bonferroni correction to assess differences 8 
across the three time points (baseline, post-PR and 3-months post-PR). 9 
When data were not normally distributed, the Friedman test was used, together with the effect 10 
size estimate Kendall’s W.35 If the effect of time was significant, post hoc analyzes were 11 
conducted with Wilcoxon signed-rank tests using Bonferroni correction. 12 
As relationships between computerized respiratory sounds (F50, mean intensity, mean number 13 
of crackles and wheeze occupation rate) and secondary outcome measures are yet little 14 
understood, correlations with Pearson’s coefficient (r) or Spearman’s rho (rs) were explored.  15 
Differences on breathing parameters across time were also explored with ANOVAs for repeated 16 
measures, as the breathing pattern can play a role in the genesis of normal37 and adventitious 17 
respiratory sounds.38, 39 18 
Statistical analyzes were performed using IBM SPSS Statistics version 20.0 (IBM Corporation, 19 
Armonk, NY, USA) and plots were created using GraphPad Prism version 5.01 (GraphPad 20 
Software, Inc., La Jolla, CA, USA). The level of significance was set at .05. 21 
RESULTS 22 
Subjects 23 
A total of 51 subjects were enrolled, however the final sample comprised 41 subjects (Figure 1). 24 
(insert Figure 1) 25 
Subjects were mostly male (85%), had a mean age of 67±9 years old and a mean FEV1 of 26 
69±22% of the predicted (Table 1). There were no signiﬁcant differences between completers 27 
and dropouts with regard to any of the baseline characteristics (p>.05). 28 
(insert table 1) 29 
Secondary outcome measures 30 
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There was a significant effect over time in all secondary outcomes (p<.007; ƞ2 from .12 to .61), 1 
with the exception of FEV1 (p=.16) and SGRQ impact (p=.35) (Table 2). 2 
(insert table 2) 3 
Primary outcome measures 4 
Normal respiratory sounds 5 
The inspiratory and expiratory F50 of normal respiratory sounds changed only in the 100 to 6 
300Hz band (p=.006, ƞ2=.06 and p=.01, ƞ2=.05) (Figure 3). Inspiratory F50 was significantly 7 
lower immediately after PR and at 3-months post-PR compared to baseline (MD=-2.3(95%CI -8 
4→-0.7)Hz, p=.006 and MD=-2.1(95%CI -3.6→-0.7)Hz, p=.005). Similar changes were observed 9 
in expiratory F50 compared to baseline (MD=-1.9(95%CI -3.3→-0.5)Hz, p=.01 and MD=-10 
2(95%CI -3.6→-0.5)Hz, p=.009). 11 
No significant differences were seen in the 300 to 600Hz band (inspiration p=.42 and expiration 12 
p=.57) (Figure 2). Also no significant differences in the mean intensity of normal respiratory 13 
sounds (p>.05) were found (Figure 2). 14 
(insert figure 2) 15 
Immediately post-PR, there were weak-to-moderate relationships between inspiratory F50 (300 16 
to 600Hz band) and SGRQ symptoms (r=.57; p<.001), SGRQ total (r=.52; p=.001), rest 17 
dyspnea (r=.41; p=.008) and self-reported sputum (r=.33; p=.04). 18 
Crackles 19 
All subjects had inspiratory crackles across the different time points, however the frequency of 20 
subjects with expiratory crackles decreased across time (p=.005; Kendall’s W=.13). Expiratory 21 
crackles were present in all subjects before the intervention whereas after PR expiratory 22 
crackles were found in 34 (82.9%; p=.004) subjects and at 3-months post-PR in 37 (90.2%; 23 
p=.19) subjects. Also no significant difference was found in the frequency of subjects with 24 
expiratory crackles between post-PR and 3-months post-PR (p=.49). 25 
The mean number of inspiratory crackles did not change significantly across time (p=.51) 26 
(Figure 3). Expiratory crackles, however, changed across the three time points (p=.01; ƞ2=.07). 27 
Their mean number was significantly lower immediately after PR, compared to baseline (MD=-28 
0.8(95%CI -1.3→-0.3), p=.003) (Figure 3). 29 
(insert figure 3) 30 
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After PR, weak-to-moderate positive relationships were found between the mean number of 1 
inspiratory (r=.4; p=.01) and expiratory (r=.33; p=.04) crackles and rest dyspnea. No other 2 
relationships were found. 3 
Wheezes 4 
The frequencies of subjects with inspiratory (p=.006, Kendall’s W=.08) and expiratory (p=.002; 5 
Kendall’s W=.09) wheezes were different across time points. Twelve (29.3%) subjects 6 
presented inspiratory and 17 (41.5%) expiratory wheezes before the intervention, whereas 7 
immediately after PR they were only 6 (14.6%; p=.06) and 9 (22%; p=.01) and at 3-months 8 
post-PR, 4 (9.8%; p=.006) and 8 (19.5%; p=.004), respectively. No significant differences were 9 
observed in the frequency of subjects with inspiratory/expiratory wheezes between post-PR and 10 
3-months post-PR (p=1). 11 
Figure 5 shows the behavior of wheeze occupation rate over time of subjects with wheezes at 12 
baseline. Inspiratory wheeze occupation rate changed across the three time points (p<0.001; 13 
Kendall’s W=.51). Post hoc analysis was conducted with a Bonferroni correction. Inspiratory 14 
wheeze occupation rate was significantly lower after PR (median 0) compared to the baseline 15 
(median 5.9, p=.001). Expiratory wheeze occupation rate changed significantly across time 16 
(p<0.003; Kendall’s W=.31), however, during post-hoc tests no significant results were found. 17 
Only a tendency for lower expiratory wheeze occupation rate after PR (median 0.8) compared 18 
to baseline (median 8.9) (p=.04) was observed (Figure 4). 19 
(insert figure 4) 20 
In subjects with no inspiratory (n=29; 70.7%) or expiratory (n=24; 58.5%) wheezes at baseline, 21 
no significant differences in the behavior of inspiratory (medians of 0 at baseline, post-PR and 22 
3-months post-PR; p=.77) or expiratory (medians of 0 at baseline and 3-months post-PR and 23 
median of 2 post-PR; p=.54) wheeze occupation rates were found across the three time points. 24 
A moderate correlation between expiratory wheeze occupation rate and FEV1 was verified (rs=-25 
.35; p=.03) before the intervention. No other relationships were found. 26 
Breathing pattern 27 
No significant differences over time were observed on inspiratory/expiratory flow (p=.06 and 28 
p=.12), volume (p=.14 and p=.18) or time (p=.48 and p=.58) during the recordings of respiratory 29 
sounds (Figure 5). 30 
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(figure 5) 1 
DISCUSSION 2 
To the best of authors’ knowledge, this was the first study investigating the effects of PR on 3 
computerized respiratory sounds in subjects with COPD. The main findings indicated that F50 4 
of normal respiratory sounds, number of crackles and wheeze occupation rate were able to 5 
detect significant differences in lung function immediately post-PR and that most of these 6 
effects were not maintained at 3 months. 7 
The mean frequency of normal respiratory sounds was sensitive to PR, while intensity remained 8 
unchanged. Similar observations were reported by Malmberg et al. which found respiratory 9 
sounds intensity at standardized airflows to be less informative than the F50 as an indicator of 10 
flow obstruction in adults with asthma and healthy subjects.40 Sánchez-Morillo et al. also found 11 
that F50 was one of the respiratory sounds parameters to better distinguish between two groups 12 
of subjects with acute exacerbation of COPD.15 Inspiratory and expiratory F50 were significantly 13 
lower immediately and at 3-months post-PR. To the authors’ knowledge, no published studies 14 
have tested the change in normal respiratory sounds after PR. Previous studies have 15 
demonstrated that higher F50 are related with pathologic events, such as bronchoconstriction 16 
and presence of pneumonia15, 40 and therefore, the decrease in F50 found in this study may 17 
reflect an improvement of lung function after PR. This decrease was only significant in the 100 18 
to 300Hz band, possibly because this frequency band is where, in stable conditions, most of the 19 
acoustic energy resides.11, 41 Nevertheless, as bronchoconstriction and sputum generate flow-20 
turbulent noise, and flow turbulence produce sounds in high frequency ranges,42 the frequency 21 
band of 300-600Hz is also of clinical importance. Positive relationships between inspiratory F50 22 
and subjects’ symptoms (SQRQ symptoms, rest dyspnea, self-reported sputum) and health-23 
related quality of life (SGRQ total) were only found at this high frequency band (300-600Hz). 24 
Future studies assessing the effects of PR on normal respiratory sounds of subjects with acute 25 
exacerbation of COPD should therefore consider both low and high frequency bands. 26 
The mean number of inspiratory crackles did not change across time, but it is well-known that 27 
COPD is characterized by inspiratory crackles.43, 44 Moreover the mean number of inspiratory 28 
crackles at the three time points was within the range of previously reported results.45-47 The 29 
mean number of expiratory crackles, however, was significantly lower immediately after PR. No 30 
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studies have investigated the change in number of crackles in subjects with COPD after PR. 1 
Nevertheless, a slight decrease in the number of expiratory crackles (from 0.8±0.8 to 0.7±0.1) 2 
after standard medical treatment has been previously reported in 11 subjects with pneumonia.47 3 
After PR the slight, but consistent, reduction in the number of expiratory crackles may be due to 4 
a combination of a number of factors. First, the active airway clearance techniques practiced 5 
during the PR program may have enhanced sputum evacuation.48, 49 A systematic review about 6 
the use of airway clearance techniques in subjects with COPD found that active airway 7 
clearance techniques were effective removing secretions.49 Second, the participation in the PR 8 
program may have optimized the use of maintenance bronchodilator therapy6 and it is known 9 
that bronchodilators act on airway smooth muscle, reducing air trapping and hyperinflation.50, 51 10 
Although not yet well understood, these airway changes might have been responsible for 11 
decreasing the genesis of crackles. Despite the possible explanatory reasons, the lower mean 12 
number of expiratory crackles after PR, seem to point out to an improvement of subjects’ lung 13 
function. A recent study showed that expiratory crackles are significantly more frequent during 14 
periods of increased disease severity (acute exacerbations of COPD) than stable periods 15 
(median 3.17 vs. 0.83).45 Additionally, a positive correlation was found between crackles and 16 
rest dyspnea. To date, there are no references in the literature about this correlation. It is 17 
believed; however, that hyperinflation may explain this relationship, as it is fundamental to the 18 
origin of dyspnea52 and may contribute to crackles’ genesis. 19 
Inspiratory wheeze occupation rate was significantly lower after PR compared to the baseline. A 20 
significant decrease in inspiratory wheeze occupation rate (from 9.2±14.1% to 0.4±1.9%) has 21 
been previously reported in 9 patients with lower respiratory tract infection after 3 weeks of 22 
pharmacotherapy plus respiratory physical therapy.53 Inspiratory wheezes have also been 23 
associated with more severe airway obstruction in patients with asthma54 and characteristic of 24 
acute exacerbations of COPD.45 Based on this evidence, it is possible that the significant 25 
decrease in inspiratory wheeze occupation rate observed in this study reflects an improvement 26 
on subjects’ airway obstruction after PR. Wheeze occupation rate during expiration did not 27 
change with PR. Expiratory wheezes, in contrast with inspiratory wheezes, are a common sign 28 
in subjects with COPD14, 46 and baseline values were in line with earlier studies.46 It was also 29 
verified that severity of airflow limitation was correlated with expiratory wheeze occupation rate, 30 
Page 12 of 49Respiratory Care
For Peer Review
13 
 
with lower values of FEV1 producing higher wheeze occupation rate, as previously shown by Fiz 1 
et al. 2 
No short- or mid-term improvement in FEV1 was observed after PR, which is in agreement with 3 
previous studies.55, 56 In light of this research, it has been established that PR does not improve 4 
lung function in COPD.6 However, FEV1 is only one possible parameter to measure lung 5 
function, inspiratory capacity, diffusing capacity and respiratory sound parameters are examples 6 
of other possible surrogate outcomes.4 In this study, the potential of computerized respiratory 7 
sounds for assessing the short-term effect of PR on lung function has been shown. This 8 
noteworthy finding demonstrates that respiratory sounds are a more sensitive indicator on the 9 
status of lung function, than FEV1, which is in line with the study from Gavriely et al.
57 In this 10 
study, half of subjects with a history compatible with COPD had normal spirometry and 11 
abnormal respiratory sounds, revealing that airway abnormalities not detectable by standard 12 
spirometry generate abnormal acoustic signals.57 Our results also demonstrate that, in the 13 
absence of a maintenance strategy, the significant effects of PR on respiratory sound 14 
parameters are no longer present at 3 months post-PR, whilst in the secondary outcomes the 15 
decline will probably only be noted later.58 This finding therefore points out to the importance of 16 
keeping subjects motivated in changing behaviors after the program to maintain the benefits. 17 
Strengths and limitations 18 
Recordings of respiratory sounds were made in the sitting position on two standardized chest 19 
locations, in line with the CORSA guidelines.59 This will facilitate the comparison of these results 20 
with other studies. It could be argued that changes observed in normal and adventitious 21 
respiratory sounds after PR could be due to subjects’ breathing pattern changes. However, to 22 
account for this bias, airflow was standardized during all respiratory sound recordings. 23 
Moreover, an analysis of the breathing pattern parameters showed that no changes over time 24 
were observed. In addition, respiratory sounds were recorded at an airflow of 0.4–0.6 l/s, which 25 
has already been shown to be reliable in subjects with COPD.28 Nonetheless, the interpretation 26 
of the results from this study should be tempered considering the following limitations. 27 
Computerized respiratory sounds have high inter-subject variability among subjects with 28 
COPD.28 To minimize the bias, each subjects served as his/her own control, but a control group 29 
was not included. Future research examining changes in respiratory acoustics could use cross-30 
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over designs to overcome the high inter-subject variability of computerized respiratory sounds.28 1 
In these studies, any component that is related to the differences between subjects can be 2 
removed from comparisons.60 To confirm the stability of subjects’ respiratory acoustics, two 3 
baseline computerized respiratory sound recordings were collected with only 1-week interval. 4 
An additional recording (e.g., one month before the intervention) could have been performed, as 5 
symptoms in subjects with COPD are characterized by weekly variability61. However, as no 6 
research has been conducted on this topic, these limitations do not appear to remove the 7 
validity and importance of the results found and will inform further study designs. The sample 8 
included mainly subjects with early COPD (mild and moderate), and thus it was not possible to 9 
explore how the disease severity related to the sensitivity to change of respiratory sound 10 
parameters. Future studies should use a more balanced sample of COPD grades to clarify 11 
these findings. This study only assessed the short- and mid-term effects of PR on computerized 12 
respiratory sounds, thus, the long-term effects of PR could not be established. Future studies 13 
with long-term follow-ups are therefore needed. The complex set up used to record respiratory 14 
sounds and airflow can also be seen as a limitation of the study and restricts the application of 15 
computerized respiratory sounds in day-to-day clinical practice. As computerized RS shows 16 
promise, research should focus in developing technological solutions to acquire RS and airflow 17 
with minimal setup. 18 
CONCLUSIONS 19 
Median frequency of normal respiratory sounds, mean number of crackles and wheeze 20 
occupation rate are sensitive outcomes to measure the short- and mid-term effects of PR in 21 
subjects with COPD. Future research is needed to strengthen these findings and to extend 22 
these observations to other clinical interventions and respiratory diseases. 23 
 24 
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Figure captions: 1 
Figure 1 - Flow of subjects throughout the study. 2 
Figure 2 – Median frequency (F50 – A and B) and mean intensity (Imean – C and D) of normal 3 
respiratory sounds at two frequency bands (100-300Hz and 300-600Hz) across time (n=41). 4 
Data are presented as mean ± 95% confidence intervals. Significant different from baseline (*). 5 
PR, pulmonary rehabilitation; 3M, 3-months. 6 
Figure 3 – Mean number of inspiratory (A) and expiratory (B) crackles across time. Data are 7 
presented as mean±95% confidence intervals (n=41). Significant different from baseline (*).  8 
PR, pulmonary rehabilitation; 3M, 3-months. 9 
Figure 4 – Wheeze occupation rate during inspiration (A, n=12) and expiration (B, n=17) across 10 
time. Data are presented as box and whisker plots with median, interquartile ranges and 5-95% 11 
percentiles. Significant different from baseline (*). PR, pulmonary rehabilitation; 3M, 3-months. 12 
Figure 5 – Inspiratory and expiratory flow (A), volume (B) and time (C) across the three time 13 
points (n=41). Data are presented as mean ± 95% confidence intervals. PR, pulmonary 14 
rehabilitation; 3M, 3-months. 15 
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Quick Look 1 
Current knowledge 2 
Based on FEV1, it has been generally established that pulmonary rehabilitation does not 3 
improve lung function in COPD. Nevertheless, FEV1 mainly reflects structural changes in the 4 
large airways and it is well-recognized that COPD primarily targets small airways. Computerized 5 
respiratory sounds are a non-invasive measure to assess lung function, but their potential to 6 
detect changes in lung function after pulmonary rehabilitation is unknown. 7 
 8 
What this paper contributes to our knowledge 9 
Computerized respiratory sounds parameters, namely median frequency of normal respiratory 10 
sounds, mean number of crackles and wheeze occupation rate, can be used to measure the 11 
short- and mid-term effects of pulmonary rehabilitation in subjects with COPD. 12 
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Abstract 1 
Introduction: Computerized respiratory sounds (CRS) are a simple and non-invasive measure to 2 
assess lung function. Nevertheless, their potential to detect changes after pulmonary 3 
rehabilitation (PR) is unknown and needs clarification if respiratory acoustics are to be used in 4 
clinical practice. Thus, this study investigated the short- and mid-term effects of PR on CRS in 5 
subjects with COPD. 6 
Methods: 41 subjects with COPD completed a 12-week PR program and a 3-month follow-up. 7 
Secondary outcome measures included dyspnea, self-reported sputum, FEV1, exercise 8 
tolerance, self-reported physical activity, health-related quality of life and peripheral muscle 9 
strength. CRS, the primary outcomes, were recorded at right/left posterior chest using two 10 
stethoscopes. Airflow was recorded with a pneumotachograph. Normal respiratory sounds, 11 
crackles and wheezes were analyzed with validated algorithms.  12 
Results: There was a significant effect over time in all secondary outcomes, with the exception 13 
of FEV1 and of the impact domain of the St. George’s Respiratory Questionnaire. Inspiratory and 14 
expiratory median frequency of normal respiratory sounds in the 100-300Hz band were 15 
significantly lower immediately (MD=-2.3Hz, 95%CI -4→-0.7 and MD=-1.9Hz, 95%CI -3.3→-0.5) 16 
and at 3-months (MD=-2.1Hz, 95%CI -3.6→-0.7 and MD=-2Hz, 95%CI -3.6→-0.5) post-PR. 17 
Mean number of expiratory crackles (MD=-0.8, 95%CI -1.3→-0.3) and inspiratory wheeze 18 
occupation rate (median 5.9 vs 0) were significantly lower immediately post-PR.  19 
Conclusions: CRS are sensitive to short- and mid-term effects of PR in subjects with COPD. 20 
These findings are encouraging for the clinical use of respiratory acoustics. Future research is 21 
needed to strengthen these findings and explore the potential of CRS to assess the 22 
effectiveness of other clinical interventions in COPD. 23 
 24 
Keywords: chronic lung disease; rehabilitation; computerized respiratory sounds  25 
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INTRODUCTION 1 
Chronic Obstructive Pulmonary Disease (COPD) affects 210 million people worldwide,1 placing 2 
a substantial burden on healthcare systems.2 According to the Global Initiative for Chronic 3 
Obstructive Lung Disease (GOLD), COPD is characterized by a persistent and progressive 4 
airflow limitation, but also by its systemic consequences, mainly exacerbations and 5 
comorbidities.3 Clinical manifestations are thus highly variable and no single outcome is able to 6 
assess the effectiveness of therapeutic interventions.4 In line with this evidence, the latest 7 
American Thoracic Society/European Respiratory Society research statement in COPD 8 
recognizes that the effectiveness of interventions in COPD should be established using both 9 
patient-centered and surrogate outcomes.5 10 
Pulmonary rehabilitation (PR) is one of the core components of the management of subjects 11 
with COPD.6 Patient-centered outcomes, namely health-related quality of life, exercise capacity 12 
and dyspnea, have been identified as the most important outcomes of PR.7 Surrogate 13 
outcomes, such as the forced expiratory volume in 1 second (FEV1), have also been used.
8, 9 14 
However, unlike the other outcomes, FEV1 has not been found to be responsive to PR.
8, 9 15 
Based on this evidence, and in the absence of other globally accepted surrogate outcome for 16 
lung function, it has been generally established that PR does not improve lung function in 17 
COPD.6 Nevertheless, FEV1 mainly reflects structural changes in the large airways
10 and it is 18 
well-recognized that COPD primarily targets small airways.3 Hence, there is a need to explore 19 
new surrogate outcomes to assess the effects of PR on lung function. 20 
Computerized respiratory sounds are a simple, objective and non-invasive surrogate measure 21 
to assess the function of the respiratory system.11 Computerized respiratory sounds can be 22 
divided in two main types, normal and adventitious sounds.12 Normal respiratory sounds are 23 
generated by the airflow in the respiratory tract and characterized by broad spectrum noise.12 24 
Adventitious respiratory sounds are additional sounds, which can be continuous (wheezes) or 25 
discontinuous (crackles).12 Both normal and adventitious respiratory sounds are directly related 26 
to movement of air, changes within lung morphology and presence of secretions.11, 13 In 27 
subjects with COPD, it has been shown that the number of detected wheezes, as well as their 28 
frequency, during forced expiratory maneuvers decreased after inhalation of terbutaline.14 It has 29 
also been demonstrated that it is possible to characterize the course of acute exacerbations of 30 
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COPD in two different respiratory sound patterns based on the variation of spectral 1 
parameters.15 From the limited evidence, it can be hypothesized that computerized respiratory 2 
sounds have potential to detect changes in lung function after PR. However, this is unknown as 3 
this measure has never been used to assess this intervention. 4 
Thus, this study primarily aimed to investigate the short- and mid-term effects of PR on 5 
computerized respiratory sounds in subjects with COPD. The secondary aim was to explore 6 
correlations between computerized respiratory sounds and patient-centered outcomes. 7 
METHODS 8 
Design and Subjects 9 
This was a one-arm longitudinal study investigating the effects of PR on computerized 10 
respiratory sounds in subjects with COPD. Subjects with COPD were recruited from two primary 11 
care centers. Inclusion criteria were i) diagnosis of COPD according to the GOLD,3 ii) age ≥40 12 
years old and iii) clinical stability for 1 month prior to the study (i.e., no hospital admissions or 13 
exacerbations as defined by the GOLD or changes in medication for the respiratory system).3 14 
Subjects were excluded if they presented severe psychiatric, neurologic or musculoskeletal 15 
conditions16 and/or unstable cardiovascular disease that could interfere with their performance 16 
during the exercise training sessions. The study was approved by the Center Health Regional 17 
Administration (2013-05-02) and from the National Data Protection Committee (3292/2013). 18 
Eligible subjects, identified via clinicians, were contacted by the researchers, who explained the 19 
purpose of the study and asked about their willingness to participate. When subjects agreed to 20 
participate, an appointment with the researchers was scheduled. Written informed consent was 21 
obtained prior to data collection. 22 
Intervention 23 
The PR program was held for 12 weeks and was composed of 3 weekly sessions of exercise 24 
training and 1 weekly session of psychoeducation. A detailed description of the program is 25 
provided elsewhere.17 26 
Data Collection 27 
Data were collected before and immediately after PR and then at 3-months post-PR. Two 28 
baseline computerized respiratory sound recordings with a 1-week interval before the 29 
intervention (hereafter referred to as baselines 1 and 2) were collected to confirm the stability of 30 
Page 25 of 49 Respiratory Care
For Peer Review
5 
 
subjects’ respiratory acoustics.18, 19 At baseline 1, socio-demographic, anthropometric (height 1 
and weight) and clinical (smoking habits, exacerbations in the previous year) data were first 2 
obtained. Dyspnea was assessed with the Modified British Medical Research Council (mMRC) 3 
questionnaire.3 Then, computerized respiratory sounds were recorded. 4 
Dyspnea at rest, self-reported sputum, computerized respiratory sounds, lung function, exercise 5 
tolerance, self-reported physical activity, health related quality of life and peripheral muscle 6 
strength were assessed at baseline 2 (immediately pre-PR), immediately post-PR and at 3-7 
months post-PR. Subjects’ were classified using both the GOLD spirometric classification (mild, 8 
moderate, severe-to-very severe) and the GOLD combined assessment (A, B, C and D).3 All 9 
assessments were performed by two physiotherapists and the order was standardized. 10 
Outcome Measures 11 
Secondary outcomes 12 
Dyspnea. Dyspnea at rest was assessed with the modified Borg scale.20 Subjects were asked to 13 
rate their dyspnea from 0 to 10. 14 
Self-reported sputum. Self-reported sputum was assessed using a numerical rating scale from 0 15 
to 10 anchored at either end with a statement (‘no sputum at all’=0; ‘the worst sputum 16 
imaginable’=10). Subjects were asked to select the number that best represented their 17 
subjective perception.21 18 
Lung function. A spirometric test, using a portable spirometer (MicroLab 3500, CareFusion, 19 
Kent, UK), was performed according to standardized guidelines.22 20 
Exercise tolerance. Exercise tolerance was measured using the 6-minute walk test (6MWT). 21 
Two tests were performed according to the protocol described by the American Thoracic 22 
Society23 and the best performance was considered. 23 
Peripheral muscle strength. The knee extensors muscle strength of the dominant limb was 24 
determined by 1 repetition maximum (Multigym Plus G112X, Vitoria-Gasteiz, ES).24 25 
Self-reported physical activity. The brief physical activity assessment tool, which consists of two 26 
questions assessing the frequency/duration of vigorous and moderate physical activity 27 
undertaken in a ‘‘usual’’ week, was used.25 A score higher or equal to 4 indicates that the 28 
subject is sufficiently active.25 29 
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Health-related quality of life. The St. George’s Respiratory Questionnaire (SGRQ), with its three 1 
domains (symptoms, activities and impact), was used.26 Scores range from 0 (no impairment) to 2 
100 (maximum impairment). 3 
Primary outcomes 4 
Computerized respiratory sounds. After 5-min of quiet sitting, airflow and respiratory sounds 5 
were acquired simultaneously during 20 seconds.27 Subjects were in a seated-upright position, 6 
wearing a nose clip and breathing through a mouthpiece connected to a heated 7 
pneumotachograph (3830, Hans Rudolph, Inc., Shawnee, KS, USA). A peak airflow of 0.4–0.6 8 
l/s was selected as computerized respiratory sounds have been shown to be reliable at this 9 
airflow range in subjects with COPD.28 Subjects had visual biofeedback of the flow signal (RSS 10 
100R Research Pneumotach System, Hans Rudolph, Shawnee, KS, USA) and were instructed 11 
to maintain the flow between two horizontal lines. Recording was preceded by a training phase 12 
of at least 3 breathing cycles. 13 
Recordings were performed simultaneously at right and left posterior chest (5 cm laterally from 14 
the paravertebral line and 7 cm below the scapular angle)29 using the LungSounds@UA 15 
interface.30 Two chest pieces (Classic II S.E., Littmann®, 3M, St. Paul, MN, USA), with a 16 
microphone (frequency response between 20Hz and 19kHz - TOM-1545P-R, Projects 17 
Unlimited, Inc.®, Dayton, OH, USA) and preamplifier circuit (Intelligent Sensing Anywhere®, 18 
Coimbra, PT) in the main tube, were attached to the subject’s skin with adhesive tape (Soft 19 
Cloth Surgical Tape, 3M, St. Paul, MN, USA). The analogue sound signals were further 20 
amplified and converted to digital by an audio interface (M-Audio® ProFire 2626, Irwindale, CA, 21 
USA). The signal was converted with a 24-bit resolution at a sampling rate of 44.1kHz and 22 
recorded in .wav format. 23 
All generated files were processed using algorithms written in Matlab®R2009a (Mathworks, 24 
Natick, MA, USA). Breathing phases were automatically detected using the positive and 25 
negative airflow signals. Mean inspiratory and expiratory time were then calculated. The mean 26 
airflows and tidal volumes were calculated per breathing phase using flow and volume raw 27 
signals. The flow was timed synchronized with the sound to combine the detected breathing 28 
phases with sound signals. 29 
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Crackles were detected using a multi-algorithm technique based on established algorithms.31 1 
This multi-algorithm technique showed a 7% performance improvement over the best individual 2 
algorithm.31 Wheezes were detected using an algorithm based on time-frequency analysis.32 3 
The mean number of crackles and the wheeze occupation rate (proportion of the breathing 4 
phase occupied by wheezes) during inspiration and expiration were extracted per chest location 5 
(right and left posterior chest). 6 
Normal respiratory sounds were analyzed based on the methodology proposed by 7 
Pasterkamp,33 after excluding adventitious respiratory sounds. The median frequency (F50) and 8 
the mean intensity were determined for the two most commonly analyzed frequency bands, i.e., 9 
100 to 300Hz and 300 to 600Hz and extracted per breathing phase and per chest location.33, 34 10 
Statistical Analysis 11 
A power calculation was not performed since there is no published data using computerized 12 
respiratory sounds to assess the effects of PR in subjects with COPD. Descriptive statistics 13 
were used to describe the sample and to examine the outcome measures. Differences between 14 
subjects who completed the study and dropouts were tested using independent t-tests for 15 
continuous normally distributed data, Mann-Whitney U tests for continuous non-normally 16 
distributed data and chi-square tests for categorical data.  17 
Computerized respiratory sounds were explored between right and left posterior chest, 18 
however, no significant differences were found. Hence, data from both locations were pooled to 19 
simplify the interpretability of the findings. 20 
Computerized respiratory sounds and breathing pattern (inspiratory/expiratory airflow, volume 21 
and time) parameters were compared between baseline 1 and baseline 2 with paired t-tests for 22 
normally distributed data or Wilcoxon signed-rank test for non-normally distributed data. After 23 
confirming that there were no significant differences, baseline 2, hereafter referred as baseline, 24 
was used for further analysis. 25 
Subjects were considered to have crackles or wheezes if they had at least a mean of one 26 
crackle/wheeze at baseline. To investigate differences in the number of subjects with 27 
crackles/wheezes across time points the Cochran Q test was used and the Kendall’s coefficient 28 
of concordance (Kendall’s W) was reported as estimate of effect size.35 This coefficient was 29 
interpreted as follows: very weak (0-.20), weak (.20-.40), moderate (.40-.60), strong (.60-.80) 30 
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and very strong (.80-1.00) effect.35 If the effect of time was significant, pairwise comparisons 1 
were performed using Bonferroni correction.  2 
Normality was verified for all outcome measures. When data were normally distributed, one-way 3 
analysis of variance (ANOVA) with repeated measures was used to establish the effects of time. 4 
The effect size was computed via Partial eta-squared as it is the index more commonly reported 5 
in the analysis of variance.36 Partial eta-squared (ƞ2) was interpreted as a small (≥.01), medium 6 
(≥.06) or large (≥.14) effect.36 When the effect of time was significant, post hoc analyzes were 7 
conducted with pairwise comparisons using the Bonferroni correction to assess differences 8 
across the three time points (baseline, post-PR and 3-months post-PR). 9 
When data were not normally distributed, the Friedman test was used, together with the effect 10 
size estimate Kendall’s W.35 If the effect of time was significant, post hoc analyzes were 11 
conducted with Wilcoxon signed-rank tests using Bonferroni correction. 12 
As relationships between computerized respiratory sounds (F50, mean intensity, mean number 13 
of crackles and wheeze occupation rate) and secondary outcome measures are yet little 14 
understood, correlations with Pearson’s coefficient (r) or Spearman’s rho (rs) were explored.  15 
Differences on breathing parameters across time were also explored with ANOVAs for repeated 16 
measures, as the breathing pattern can play a role in the genesis of normal37 and adventitious 17 
respiratory sounds.38, 39 18 
Statistical analyzes were performed using IBM SPSS Statistics version 20.0 (IBM Corporation, 19 
Armonk, NY, USA) and plots were created using GraphPad Prism version 5.01 (GraphPad 20 
Software, Inc., La Jolla, CA, USA). The level of significance was set at .05. 21 
RESULTS 22 
Subjects 23 
A total of 51 subjects were enrolled, however the final sample comprised 41 subjects (Figure 1). 24 
(insert Figure 1) 25 
Subjects were mostly male (85%), had a mean age of 67±9 years old and a mean FEV1 of 26 
69±22% of the predicted (Table 1). There were no signiﬁcant differences between completers 27 
and dropouts with regard to any of the baseline characteristics (p>.05). 28 
(insert table 1) 29 
Secondary outcome measures 30 
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There was a significant effect over time in all secondary outcomes (p<.007; ƞ2 from .12 to .61), 1 
with the exception of FEV1 (p=.16) and SGRQ impact (p=.35) (Table 2). 2 
(insert table 2) 3 
Primary outcome measures 4 
Normal respiratory sounds 5 
The inspiratory and expiratory F50 of normal respiratory sounds changed only in the 100 to 6 
300Hz band (p=.006, ƞ2=.06 and p=.01, ƞ2=.05) (Figure 3). Inspiratory F50 was significantly 7 
lower immediately after PR and at 3-months post-PR compared to baseline (MD=-2.3(95%CI -8 
4→-0.7)Hz, p=.006 and MD=-2.1(95%CI -3.6→-0.7)Hz, p=.005). Similar changes were observed 9 
in expiratory F50 compared to baseline (MD=-1.9(95%CI -3.3→-0.5)Hz, p=.01 and MD=-10 
2(95%CI -3.6→-0.5)Hz, p=.009). 11 
No significant differences were seen in the 300 to 600Hz band (inspiration p=.42 and expiration 12 
p=.57) (Figure 2). Also no significant differences in the mean intensity of normal respiratory 13 
sounds (p>.05) were found (Figure 2). 14 
(insert figure 2) 15 
Immediately post-PR, there were weak-to-moderate relationships between inspiratory F50 (300 16 
to 600Hz band) and SGRQ symptoms (r=.57; p<.001), SGRQ total (r=.52; p=.001), rest 17 
dyspnea (r=.41; p=.008) and self-reported sputum (r=.33; p=.04). 18 
Crackles 19 
All subjects had inspiratory crackles across the different time points, however the frequency of 20 
subjects with expiratory crackles decreased across time (p=.005; Kendall’s W=.13). Expiratory 21 
crackles were present in all subjects before the intervention whereas after PR expiratory 22 
crackles were found in 34 (82.9%; p=.004) subjects and at 3-months post-PR in 37 (90.2%; 23 
p=.19) subjects. Also no significant difference was found in the frequency of subjects with 24 
expiratory crackles between post-PR and 3-months post-PR (p=.49). 25 
The mean number of inspiratory crackles did not change significantly across time (p=.51) 26 
(Figure 3). Expiratory crackles, however, changed across the three time points (p=.01; ƞ2=.07). 27 
Their mean number was significantly lower immediately after PR, compared to baseline (MD=-28 
0.8(95%CI -1.3→-0.3), p=.003) (Figure 3). 29 
(insert figure 3) 30 
Page 30 of 49Respiratory Care
For Peer Review
10 
 
After PR, weak-to-moderate positive relationships were found between the mean number of 1 
inspiratory (r=.4; p=.01) and expiratory (r=.33; p=.04) crackles and rest dyspnea. No other 2 
relationships were found. 3 
Wheezes 4 
The frequencies of subjects with inspiratory (p=.006, Kendall’s W=.08) and expiratory (p=.002; 5 
Kendall’s W=.09) wheezes were different across time points. Twelve (29.3%) subjects 6 
presented inspiratory and 17 (41.5%) expiratory wheezes before the intervention, whereas 7 
immediately after PR they were only 6 (14.6%; p=.06) and 9 (22%; p=.01) and at 3-months 8 
post-PR, 4 (9.8%; p=.006) and 8 (19.5%; p=.004), respectively. No significant differences were 9 
observed in the frequency of subjects with inspiratory/expiratory wheezes between post-PR and 10 
3-months post-PR (p=1). 11 
Figure 5 shows the behavior of wheeze occupation rate over time of subjects with wheezes at 12 
baseline. Inspiratory wheeze occupation rate changed across the three time points (p<0.001; 13 
Kendall’s W=.51). Post hoc analysis was conducted with a Bonferroni correction. Inspiratory 14 
wheeze occupation rate was significantly lower after PR (median 0) compared to the baseline 15 
(median 5.9, p=.001). Expiratory wheeze occupation rate changed significantly across time 16 
(p<0.003; Kendall’s W=.31), however, during post-hoc tests no significant results were found. 17 
Only a tendency for lower expiratory wheeze occupation rate after PR (median 0.8) compared 18 
to baseline (median 8.9) (p=.04) was observed (Figure 4). 19 
(insert figure 4) 20 
In subjects with no inspiratory (n=29; 70.7%) or expiratory (n=24; 58.5%) wheezes at baseline, 21 
no significant differences in the behavior of inspiratory (medians of 0 at baseline, post-PR and 22 
3-months post-PR; p=.77) or expiratory (medians of 0 at baseline and 3-months post-PR and 23 
median of 2 post-PR; p=.54) wheeze occupation rates were found across the three time points. 24 
A moderate correlation between expiratory wheeze occupation rate and FEV1 was verified (rs=-25 
.35; p=.03) before the intervention. No other relationships were found. 26 
Breathing pattern 27 
No significant differences over time were observed on inspiratory/expiratory flow (p=.06 and 28 
p=.12), volume (p=.14 and p=.18) or time (p=.48 and p=.58) during the recordings of respiratory 29 
sounds (Figure 5). 30 
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(figure 5) 1 
DISCUSSION 2 
To the best of authors’ knowledge, this was the first study investigating the effects of PR on 3 
computerized respiratory sounds in subjects with COPD. The main findings indicated that F50 4 
of normal respiratory sounds, number of crackles and wheeze occupation rate were able to 5 
detect significant differences in lung function immediately post-PR and that most of these 6 
effects were not maintained at 3 months. 7 
The mean frequency of normal respiratory sounds was sensitive to PR, while intensity remained 8 
unchanged. Similar observations were reported by Malmberg et al. which found respiratory 9 
sounds intensity at standardized airflows to be less informative than the F50 as an indicator of 10 
flow obstruction in adults with asthma and healthy subjects.40 Sánchez-Morillo et al. also found 11 
that F50 was one of the respiratory sounds parameters to better distinguish between two groups 12 
of subjects with acute exacerbation of COPD.15 Inspiratory and expiratory F50 were significantly 13 
lower immediately and at 3-months post-PR. To the authors’ knowledge, no published studies 14 
have tested the change in normal respiratory sounds after PR. Previous studies have 15 
demonstrated that higher F50 are related with pathologic events, such as bronchoconstriction 16 
and presence of pneumonia15, 40 and therefore, the decrease in F50 found in this study may 17 
reflect an improvement of lung function after PR. This decrease was only significant in the 100 18 
to 300Hz band, possibly because this frequency band is where, in stable conditions, most of the 19 
acoustic energy resides.11, 41 Nevertheless, as bronchoconstriction and sputum generate flow-20 
turbulent noise, and flow turbulence produce sounds in high frequency ranges,42 the frequency 21 
band of 300-600Hz is also of clinical importance. Positive relationships between inspiratory F50 22 
and subjects’ symptoms (SQRQ symptoms, rest dyspnea, self-reported sputum) and health-23 
related quality of life (SGRQ total) were only found at this high frequency band (300-600Hz). 24 
Future studies assessing the effects of PR on normal respiratory sounds of subjects with acute 25 
exacerbation of COPD should therefore consider both low and high frequency bands. 26 
The mean number of inspiratory crackles did not change across time, but it is well-known that 27 
COPD is characterized by inspiratory crackles.43, 44 Moreover the mean number of inspiratory 28 
crackles at the three time points was within the range of previously reported results.45-47 The 29 
mean number of expiratory crackles, however, was significantly lower immediately after PR. No 30 
Page 32 of 49Respiratory Care
For Peer Review
12 
 
studies have investigated the change in number of crackles in subjects with COPD after PR. 1 
Nevertheless, a slight decrease in the number of expiratory crackles (from 0.8±0.8 to 0.7±0.1) 2 
after standard medical treatment has been previously reported in 11 subjects with pneumonia.47 3 
After PR the slight, but consistent, reduction in the number of expiratory crackles may be due to 4 
a combination of a number of factors. First, the active airway clearance techniques practiced 5 
during the PR program may have enhanced sputum evacuation.48, 49 A systematic review about 6 
the use of airway clearance techniques in subjects with COPD found that active airway 7 
clearance techniques were effective removing secretions.49 Second, the participation in the PR 8 
program may have optimized the use of maintenance bronchodilator therapy6 and it is known 9 
that bronchodilators act on airway smooth muscle, reducing air trapping and hyperinflation.50, 51 10 
Although not yet well understood, these airway changes might have been responsible for 11 
decreasing the genesis of crackles. Despite the possible explanatory reasons, the lower mean 12 
number of expiratory crackles after PR, seem to point out to an improvement of subjects’ lung 13 
function. A recent study showed that expiratory crackles are significantly more frequent during 14 
periods of increased disease severity (acute exacerbations of COPD) than stable periods 15 
(median 3.17 vs. 0.83).45 Additionally, a positive correlation was found between crackles and 16 
rest dyspnea. To date, there are no references in the literature about this correlation. It is 17 
believed; however, that hyperinflation may explain this relationship, as it is fundamental to the 18 
origin of dyspnea52 and may contribute to crackles’ genesis. 19 
Inspiratory wheeze occupation rate was significantly lower after PR compared to the baseline. A 20 
significant decrease in inspiratory wheeze occupation rate (from 9.2±14.1% to 0.4±1.9%) has 21 
been previously reported in 9 patients with lower respiratory tract infection after 3 weeks of 22 
pharmacotherapy plus respiratory physical therapy.53 Inspiratory wheezes have also been 23 
associated with more severe airway obstruction in patients with asthma54 and characteristic of 24 
acute exacerbations of COPD.45 Based on this evidence, it is possible that the significant 25 
decrease in inspiratory wheeze occupation rate observed in this study reflects an improvement 26 
on subjects’ airway obstruction after PR. Wheeze occupation rate during expiration did not 27 
change with PR. Expiratory wheezes, in contrast with inspiratory wheezes, are a common sign 28 
in subjects with COPD14, 46 and baseline values were in line with earlier studies.46 It was also 29 
verified that severity of airflow limitation was correlated with expiratory wheeze occupation rate, 30 
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with lower values of FEV1 producing higher wheeze occupation rate, as previously shown by Fiz 1 
et al. 2 
No short- or mid-term improvement in FEV1 was observed after PR, which is in agreement with 3 
previous studies.55, 56 In light of this research, it has been established that PR does not improve 4 
lung function in COPD.6 However, FEV1 is only one possible parameter to measure lung 5 
function, inspiratory capacity, diffusing capacity and respiratory sound parameters are examples 6 
of other possible surrogate outcomes.4 In this study, the potential of computerized respiratory 7 
sounds for assessing the short-term effect of PR on lung function has been shown. This 8 
noteworthy finding demonstrates that respiratory sounds are a more sensitive indicator on the 9 
status of lung function, than FEV1, which is in line with the study from Gavriely et al.
57 In this 10 
study, half of subjects with a history compatible with COPD had normal spirometry and 11 
abnormal respiratory sounds, revealing that airway abnormalities not detectable by standard 12 
spirometry generate abnormal acoustic signals.57 Our results also demonstrate that, in the 13 
absence of a maintenance strategy, the significant effects of PR on respiratory sound 14 
parameters are no longer present at 3 months post-PR, whilst in the secondary outcomes the 15 
decline will probably only be noted later.58 This finding therefore points out to the importance of 16 
keeping subjects motivated in changing behaviors after the program to maintain the benefits. 17 
Strengths and limitations 18 
Recordings of respiratory sounds were made in the sitting position on two standardized chest 19 
locations, in line with the CORSA guidelines.59 This will facilitate the comparison of these results 20 
with other studies. It could be argued that changes observed in normal and adventitious 21 
respiratory sounds after PR could be due to subjects’ breathing pattern changes. However, to 22 
account for this bias, airflow was standardized during all respiratory sound recordings. 23 
Moreover, an analysis of the breathing pattern parameters showed that no changes over time 24 
were observed. In addition, respiratory sounds were recorded at an airflow of 0.4–0.6 l/s, which 25 
has already been shown to be reliable in subjects with COPD.28 Nonetheless, the interpretation 26 
of the results from this study should be tempered considering the following limitations. 27 
Computerized respiratory sounds have high inter-subject variability among subjects with 28 
COPD.28 To minimize the bias, each subjects served as his/her own control, but a control group 29 
was not included. Future research examining changes in respiratory acoustics could use cross-30 
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over designs to overcome the high inter-subject variability of computerized respiratory sounds.28 1 
In these studies, any component that is related to the differences between subjects can be 2 
removed from comparisons.60 To confirm the stability of subjects’ respiratory acoustics, two 3 
baseline computerized respiratory sound recordings were collected with only 1-week interval. 4 
An additional recording (e.g., one month before the intervention) could have been performed, as 5 
symptoms in subjects with COPD are characterized by weekly variability61. However, as no 6 
research has been conducted on this topic, these limitations do not appear to remove the 7 
validity and importance of the results found and will inform further study designs. The sample 8 
included mainly subjects with early COPD (mild and moderate), and thus it was not possible to 9 
explore how the disease severity related to the sensitivity to change of respiratory sound 10 
parameters. Future studies should use a more balanced sample of COPD grades to clarify 11 
these findings. This study only assessed the short- and mid-term effects of PR on computerized 12 
respiratory sounds, thus, the long-term effects of PR could not be established. Future studies 13 
with long-term follow-ups are therefore needed. The complex set up used to record respiratory 14 
sounds and airflow can also be seen as a limitation of the study and restricts the application of 15 
computerized respiratory sounds in day-to-day clinical practice. As computerized RS shows 16 
promise, research should focus in developing technological solutions to acquire RS and airflow 17 
with minimal setup. 18 
CONCLUSIONS 19 
Median frequency of normal respiratory sounds, mean number of crackles and wheeze 20 
occupation rate are sensitive outcomes to measure the short- and mid-term effects of PR in 21 
subjects with COPD. Future research is needed to strengthen these findings and to extend 22 
these observations to other clinical interventions and respiratory diseases. 23 
 24 
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Figure captions: 1 
Figure 1 - Flow of subjects throughout the study. 2 
Figure 2 – Median frequency (F50 – A and B) and mean intensity (Imean – C and D) of normal 3 
respiratory sounds at two frequency bands (100-300Hz and 300-600Hz) across time (n=41). 4 
Data are presented as mean ± 95% confidence intervals. Significant different from baseline (*). 5 
PR, pulmonary rehabilitation; 3M, 3-months. 6 
Figure 3 – Mean number of inspiratory (A) and expiratory (B) crackles across time. Data are 7 
presented as mean±95% confidence intervals (n=41). Significant different from baseline (*).  8 
PR, pulmonary rehabilitation; 3M, 3-months. 9 
Figure 4 – Wheeze occupation rate during inspiration (A, n=12) and expiration (B, n=17) across 10 
time. Data are presented as box and whisker plots with median, interquartile ranges and 5-95% 11 
percentiles. Significant different from baseline (*). PR, pulmonary rehabilitation; 3M, 3-months. 12 
Figure 5 – Inspiratory and expiratory flow (A), volume (B) and time (C) across the three time 13 
points (n=41). Data are presented as mean ± 95% confidence intervals. PR, pulmonary 14 
rehabilitation; 3M, 3-months. 15 
  16 
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Quick Look 1 
Current knowledge 2 
Based on FEV1, it has been generally established that pulmonary rehabilitation does not 3 
improve lung function in COPD. Nevertheless, FEV1 mainly reflects structural changes in the 4 
large airways and it is well-recognized that COPD primarily targets small airways. Computerized 5 
respiratory sounds are a non-invasive measure to assess lung function, but their potential to 6 
detect changes in lung function after pulmonary rehabilitation is unknown. 7 
 8 
What this paper contributes to our knowledge 9 
Computerized respiratory sounds parameters, namely median frequency of normal respiratory 10 
sounds, mean number of crackles and wheeze occupation rate, can be used to measure the 11 
short- and mid-term effects of pulmonary rehabilitation in subjects with COPD. 12 
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Flow of subjects throughout the study.  
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Median frequency (F50 – A and B) and mean intensity (Imean – C and D) of normal respiratory sounds at 
two frequency bands (100-300Hz and 300-600Hz) across time (n=41). Data are presented as mean ± 95% 
confidence intervals. Significant different from baseline (*). PR, pulmonary rehabilitation; 3M, 3-months.  
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Mean number of inspiratory (A) and expiratory (B) crackles across time. Data are presented as mean±95% 
confidence intervals (n=41). Significant different from baseline (*).  PR, pulmonary rehabilitation; 3M, 3-
months.  
232x90mm (300 x 300 DPI)  
 
 
Page 45 of 49 Respiratory Care
For Peer Review
  
 
 
Wheeze occupation rate during inspiration (A, n=12) and expiration (B, n=17) across time. Data are 
presented as box and whisker plots with median, interquartile ranges and 5-95% percentiles. Significant 
different from baseline (*). PR, pulmonary rehabilitation; 3M, 3-months.  
275x98mm (300 x 300 DPI)  
 
 
Page 46 of 49Respiratory Care
For Peer Review
  
 
 
Inspiratory and expiratory flow (A), volume (B) and time (C) across the three time points (n=41). Data are 
presented as mean ± 95% confidence intervals. PR, pulmonary rehabilitation; 3M, 3-months.  
220x71mm (300 x 300 DPI)  
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Table 1 – Subjects’ socio-demographic and clinical characteristics (n=41). 
Characteristics  
Sex (male), n (%) 35 (85) 
Age (years) 67 ± 9 
Current smokers 8 (20) 
BMI (kg/m
2
) 28 ± 3 
mMRC, M [IQR] 1 [1, 2] 
FEV1 (% predicted[52]) 69 ± 22 
FEV1/FVC 63 ± 9 
GOLD spirometric classification, n (%)  
    Mild 17 (42) 
    Moderate 16 (39) 
    Severe-to-very-severe 8 (19) 
GOLD combined assessment, n (%)  
    A 14 (34) 
    B 15 (37) 
    C & D 12 (29) 
N=41 
Values are shown as mean±standard deviation unless otherwise indicated. mMRC, modified British Medical Research 
Council questionnaire; M, median; IQR, interquartile range; BMI, body mass index; FEV1, forced expiratory volume in 
one second; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease. 
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Table 2 – Secondary outcome measures to assess pulmonary rehabilitation across time. 
Outcome measure Baseline Immediately 
Post-PR 
3-months Post-
PR 
p-value
 
ƞ2
 
Dyspnea (0-10) 1 [0,2] 1 [0,2]* 0 [0, 1.75]* .007 .12 
Sputum (0-10) 1.5 [0, 4] 1 [0, 2]* 1 [0, 2]* .003 .15 
FEV1 (% predicted
52
) 68.9±21.7 67.1±21.8 68±21.7 .16 .05 
6MWD (m) 481.3±76.1 538.8±78.8*
 
525.2±75.5*
, # 
<.001 .51 
Knee extensors (kg) 37.9±8.5 47.5±11.5*
 
41.8±11.1*
, # 
<.001 .61 
Physical activity (0-8) 1.8±2.0 5.1±1.6*
 
3.4±2.3*
, # 
<.001 .45 
SGRQ total (0-100) 31.0±16.8 24.2±17.6*
 
22.1±12.1*
 
<.001 .27 
SGRQ symptoms (0-100) 40.6±20.8 33.0±18.8* 27.3±20.0* .003 .14 
SGRQ activities (0-100) 46.9±19.6 36.1±22.9 28.6±22.1 <.001 .19 
SGRQ impact (0-100) 18.7±16.9 14.5±17.1 15.3±16.5 .35 .03 
N=41 
Data are presented as mean±standard deviation. 6MWD, 6-minute walk distance; FEV1, forced expiratory volume in one 
second; PR, pulmonary rehabilitation; SGRQ, St. George’s Respiratory Questionnaire; ƞ
2
, partial eta-squared. 
Significantly different from baseline (*) and from post-PR (#). 
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